Rose Limaye

rose-limaye

Rose Limaye

Associate

London | 160 Queen Victoria Street, London, UK EC4V 4QQ
+44 20 7184 7448 | +44 20 7184 7001

| vCard | PDF

Rose Limaye focuses her practice on corporate and securities matters with an emphasis on corporate transactions, including mergers and acquisitions, fundraisings, public offerings, and reorganizations.

Ms. Limaye joined Dechert in 2015 as a trainee and qualified in 2017.

Experience
  • A substantial family office as investor in a substantive venture investment in a UK ticketing and events hosting company.
  • Merck KGaA, as deal counsel on the restructure of its ongoing collaboration and acquisition option arrangements with F-Star.
  • Stripes Group on the sale of its portfolio company Audio Network Limited to Entertainment One Limited.
  • One Equity Partners on the acquisition of the MERA group, a custom software developments services provider.
  • Quilvest Private Equity on the acquisition of global specialist recruitment firm Phaidon International.
  • Prexton Therapeutics B.V. and its selling shareholders, including M Ventures, in its sale to global pharmaceutical company H. Lundbeck A/S for up to €905 million.
  • The shareholders on the sale of Stat-Dx, a privately owned Spanish diagnostics company, to QIAGEN N.V., for US$191 million (including milestones).  

 

Education
  • University of Oxford, B.A., 2014
  • University of Law, Legal Practice Course, 2015
Admissions
  • England and Wales, 2017